焦磷酸钙晶体沉积病新兴诊断措施的系统评价与质量分析
该系统评价更新了2009至2016年文献,纳入26篇论文,评估超声、双能CT和拉曼光谱等新兴诊断措施。超声检测外周关节焦磷酸钙晶体的灵敏度>80%,优于X线摄影,但多数研究证据等级低且偏倚风险高。传统晶体分析和X线摄影仍是参考标准,随机盲法对照研究等需求未满足。
要点
- 超声检测外周关节焦磷酸钙晶体灵敏度>80%,优于X线摄影。
- 双能CT和拉曼光谱在焦磷酸钙晶体沉积病中探索有限。
- 多数研究证据等级低,约30%论文存在高偏倚风险。
核心结论
- 传统晶体分析和X线摄影仍是焦磷酸钙晶体沉积病诊断的参考标准。
- 超声、双能CT和拉曼光谱是新兴诊断措施,其中超声灵敏度似乎优于X线摄影。
- 焦磷酸钙晶体沉积病诊断性能的随机盲法对照研究等重大需求未满足。
研究设计与样本
- 系统检索PubMed、Scopus/EMBASE和Cochrane数据库2009至2016年全文论文。
- 检索词包括焦磷酸钙晶体沉积病、软骨钙化、假性痛风、超声、MRI和双能CT。
- 由3名作者独立进行论文选择、数据提取、EULAR证据等级和QUADAS-2偏倚及适用性分级。
- 共纳入111篇合格论文中的26篇。
主要发现
- 超声检测外周关节焦磷酸钙晶体灵敏度>80%,优于X线摄影。
- 双能CT在焦磷酸钙晶体沉积病中探索有限,相比痛风有35篇已发表双能CT研究。
- QUADAS-2分级显示超声、双能CT和拉曼光谱适用性强,但约30%论文因非对照设计和非随机受试者选择存在高偏倚风险。
- 大多数研究设计虽为分析性,但EULAR证据等级低。
关键数值与推荐
- 超声检测外周关节焦磷酸钙晶体灵敏度>80%,优于X线摄影。
- 双能CT在焦磷酸钙晶体沉积病中探索有限,相比痛风有35篇已发表双能CT研究。
- 约30%论文存在高偏倚风险,因非对照设计和非随机受试者选择。
临床怎么用
- 临床可考虑使用超声辅助诊断外周关节焦磷酸钙晶体沉积病,其灵敏度优于X线摄影。
- 传统晶体分析和X线摄影仍应作为焦磷酸钙晶体沉积病诊断的参考标准。
- 应用新兴诊断措施时需注意现有研究证据等级低和高偏倚风险。
局限性
- 大多数研究设计虽为分析性,但EULAR证据等级低。
- 约30%论文存在高偏倚风险,因非对照设计和非随机受试者选择。
- 双能CT在焦磷酸钙晶体沉积病中探索有限。
- 缺乏随机盲法对照的焦磷酸钙晶体沉积病诊断性能研究。
- 4T MRI和其他新兴模式的严格分析未满足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Calcium pyrophosphate crystal deposition disease (CPPD) is common, yet prevalence and overall clinical impact remain unclear. Sensitivity and specificity of CPPD reference standards (conventional crystal analysis (CCA) and radiography (CR)) were meta-analysed by EULAR (published 2011). Since then, new diagnostic modalities are emerging. Hence, we updated 2009-2016 literature findings by systematic review and evidence grading, and assessed unmet needs. METHODS: We performed systematic search of full papers (PubMed, Scopus/EMBASE, Cochrane 2009-2016 databases). Search terms included CPPD, chondrocalcinosis, pseudogout, ultrasound, MRI, dual energy CT (DECT). Paper selection, data abstraction, EULAR evidence level, and Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 bias and applicability grading were performed independently by 3 authors. RESULTS: We included 26 of 111 eligible papers, which showed emergence in CPPD diagnosis of ultrasound (U/S), and to lesser degree, DECT and Raman spectroscopy. U/S detected CPPD crystals in peripheral joints with sensitivity >80%, superior to CR. However, most study designs, though analytical, yielded low EULAR evidence level. DECT was marginally explored for CPPD, compared with 35 published DECT studies in gout. QUADAS-2 grading indicated strong applicability of U/S, DECT and Raman spectroscopy, but high study bias risk (in ∼30% of papers) due to non-controlled designs, and non-randomised subject selection. CONCLUSIONS: Though CCA and CR remain reference standards for CPPD diagnosis, U/S, DECT and Raman spectroscopy are emerging U/S sensitivity appears to be superior to CR. We identified major unmet needs, including for randomised, blinded, controlled studies of CPPD diagnostic performance and rigorous analyses of 4 T MRI and other emerging modalities.
引用
- Wu Y, Chen K, Terkeltaub R, et al. Systematic review and quality analysis of emerging diagnostic measures for calcium pyrophosphate crystal deposition disease. RMD Open. 2016. PMID: 27933211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。